Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.
<h4>Background</h4>Autotaxin (ATX) and its product lysophosphatidic acid (LPA) are considered to be involved in the development of liver fibrosis and elevated levels of serum ATX have been found in patients with hepatitis C virus associated liver fibrosis. However, the clinical role of s...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f85ff14292e741c48d9e01f2f8ef19b1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f85ff14292e741c48d9e01f2f8ef19b1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f85ff14292e741c48d9e01f2f8ef19b12021-11-25T06:07:04ZSerum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.1932-620310.1371/journal.pone.0103532https://doaj.org/article/f85ff14292e741c48d9e01f2f8ef19b12014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25062038/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Autotaxin (ATX) and its product lysophosphatidic acid (LPA) are considered to be involved in the development of liver fibrosis and elevated levels of serum ATX have been found in patients with hepatitis C virus associated liver fibrosis. However, the clinical role of systemic ATX in the stages of liver cirrhosis was unknown. Here we investigated the relation of ATX serum levels and severity of cirrhosis as well as prognosis of cirrhotic patients.<h4>Methods</h4>Patients with liver cirrhosis were prospectively enrolled and followed until death, liver transplantation or last contact. Blood samples drawn at the day of inclusion in the study were assessed for ATX content by an enzyme-linked immunosorbent assay. ATX levels were correlated with the stage as well as complications of cirrhosis. The prognostic value of ATX was investigated by uni- and multivariate Cox regression analyses. LPA concentration was determined by liquid chromatography-tandem mass spectrometry.<h4>Results</h4>270 patients were enrolled. Subjects with liver cirrhosis showed elevated serum levels of ATX as compared to healthy subjects (0.814±0.42 mg/l vs. 0.258±0.40 mg/l, P<0.001). Serum ATX levels correlated with the Child-Pugh stage and the MELD (model of end stage liver disease) score and LPA levels (r = 0.493, P = 0.027). Patients with hepatic encephalopathy (P = 0.006), esophageal varices (P = 0.002) and portal hypertensive gastropathy (P = 0.008) had higher ATX levels than patients without these complications. Low ATX levels were a parameter independently associated with longer overall survival (hazard ratio 0.575, 95% confidence interval 0.365-0.905, P = 0.017).<h4>Conclusion</h4>Serum ATX is an indicator for the severity of liver disease and the prognosis of cirrhotic patients.Thomas PleliDaniel MartinBernd KronenbergerFriederike BrunnerVerena KöberleGeorgios GrammatikosHarald FarnikYolanda MartinezFabian FinkelmeierSandra LabochaNerea FerreirósStefan ZeuzemAlbrecht PiiperOliver WaidmannPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 7, p e103532 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Thomas Pleli Daniel Martin Bernd Kronenberger Friederike Brunner Verena Köberle Georgios Grammatikos Harald Farnik Yolanda Martinez Fabian Finkelmeier Sandra Labocha Nerea Ferreirós Stefan Zeuzem Albrecht Piiper Oliver Waidmann Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| description |
<h4>Background</h4>Autotaxin (ATX) and its product lysophosphatidic acid (LPA) are considered to be involved in the development of liver fibrosis and elevated levels of serum ATX have been found in patients with hepatitis C virus associated liver fibrosis. However, the clinical role of systemic ATX in the stages of liver cirrhosis was unknown. Here we investigated the relation of ATX serum levels and severity of cirrhosis as well as prognosis of cirrhotic patients.<h4>Methods</h4>Patients with liver cirrhosis were prospectively enrolled and followed until death, liver transplantation or last contact. Blood samples drawn at the day of inclusion in the study were assessed for ATX content by an enzyme-linked immunosorbent assay. ATX levels were correlated with the stage as well as complications of cirrhosis. The prognostic value of ATX was investigated by uni- and multivariate Cox regression analyses. LPA concentration was determined by liquid chromatography-tandem mass spectrometry.<h4>Results</h4>270 patients were enrolled. Subjects with liver cirrhosis showed elevated serum levels of ATX as compared to healthy subjects (0.814±0.42 mg/l vs. 0.258±0.40 mg/l, P<0.001). Serum ATX levels correlated with the Child-Pugh stage and the MELD (model of end stage liver disease) score and LPA levels (r = 0.493, P = 0.027). Patients with hepatic encephalopathy (P = 0.006), esophageal varices (P = 0.002) and portal hypertensive gastropathy (P = 0.008) had higher ATX levels than patients without these complications. Low ATX levels were a parameter independently associated with longer overall survival (hazard ratio 0.575, 95% confidence interval 0.365-0.905, P = 0.017).<h4>Conclusion</h4>Serum ATX is an indicator for the severity of liver disease and the prognosis of cirrhotic patients. |
| format |
article |
| author |
Thomas Pleli Daniel Martin Bernd Kronenberger Friederike Brunner Verena Köberle Georgios Grammatikos Harald Farnik Yolanda Martinez Fabian Finkelmeier Sandra Labocha Nerea Ferreirós Stefan Zeuzem Albrecht Piiper Oliver Waidmann |
| author_facet |
Thomas Pleli Daniel Martin Bernd Kronenberger Friederike Brunner Verena Köberle Georgios Grammatikos Harald Farnik Yolanda Martinez Fabian Finkelmeier Sandra Labocha Nerea Ferreirós Stefan Zeuzem Albrecht Piiper Oliver Waidmann |
| author_sort |
Thomas Pleli |
| title |
Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| title_short |
Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| title_full |
Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| title_fullStr |
Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| title_full_unstemmed |
Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| title_sort |
serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/f85ff14292e741c48d9e01f2f8ef19b1 |
| work_keys_str_mv |
AT thomaspleli serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT danielmartin serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT berndkronenberger serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT friederikebrunner serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT verenakoberle serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT georgiosgrammatikos serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT haraldfarnik serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT yolandamartinez serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT fabianfinkelmeier serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT sandralabocha serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT nereaferreiros serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT stefanzeuzem serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT albrechtpiiper serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy AT oliverwaidmann serumautotaxinisaparameterfortheseverityoflivercirrhosisandoverallsurvivalinpatientswithlivercirrhosisaprospectivecohortstudy |
| _version_ |
1718414199921573888 |